Quantitative salivary proteomic differences in oral chronic graft-versus-host disease

Journal of Clinical Immunology

Volumn 32, Issue 6, 2012, Pages 1390-1399

  Bassim, Carol W ^a   Ambatipudi, Kiran S ^a   Mays, Jacqueline W ^a   Edwards, Dean A ^a   Swatkoski, Stephan ^c   Fassil, Helen ^b   Baird, Kristin ^b   Gucek, Marjan ^c   Melvin, James E ^a   Pavletic, Steven Z ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

biomarker; graft versus host; GVHD; label free quantitation; oral; proteomics; Saliva; transplant

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; LACTOFERRIN; LACTOPEROXIDASE; SALIVA PROTEIN; ALBUMINOID; CYSTEINE PROTEINASE INHIBITOR; LTF PROTEIN, HUMAN;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CELL METABOLISM; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DOWN REGULATION; FEASIBILITY STUDY; HUMAN; IMMUNOREGULATION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MOUTH DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEOMICS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SALIVA ANALYSIS; TANDEM MASS SPECTROMETRY; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SALIVA;

ADULT; ALBUMINS; CHROMATOGRAPHY, LIQUID; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; CYSTEINE PROTEINASE INHIBITORS; FEMALE; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LACTOFERRIN; LACTOPEROXIDASE; MALE; MIDDLE AGED; PROTEOMICS; RETROSPECTIVE STUDIES; SALIVA; SALIVARY PROTEINS AND PEPTIDES; TANDEM MASS SPECTROMETRY;

EID: 84878233934     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9738-4     Document Type: Article

References (42)

1. Schubert MM, Correa MEP. Oral graft-versus-host disease. Dent Clin N Am. 2008;52:79-109.
2. Fall-Dickson, J.M., et al., Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation, 2010;16(7):948-56.
3. Imanguli MM, et al. Oral graft-versus-host disease. Oral Diseases. 2008;14:396-412.
4. Imanguli, M.M., et al., Salivary gland involvement in chronic graft-versus-host disease: Prevalence, clinical significance, and recommendations for evaluations. Biology of Blood and Marrow Transplantation, 2010;16(10):1362-69.
5. Shulman HM, et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report Biol Blood Marrow Transplant. 2006;12(1):31-47.
6. Filipovich AH, et al. National Institutes of Health consensus development project on criteria for clnical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation. 2005;11:945-55.
7. Amerongen A, Veerman E. Saliva- the defender of the oral cavity. Oral Diseases. 2002;8:12-22.
8. Dodds MW, Johnson DA, Yeh CK. Health benefits of saliva: A review. J Dent. 2005;33(3):223-33.
9. Bassim C, et al. Salivary procalcitonin and periodontitis in diabetes. J Dent Res. 2008;87:630-4.
10. Lenssen O, et al. Prevalence of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc. 1990;90:835-42.
11. Ruescher T, et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer. 1998;82:2275-81.
12. Choi S, Levine J, Ferrara J. Pathogenesis and Management of Graft-versus-Host Disease. Immunol Allergy Clin N Am. 2010;30:75-101.
13. Ambatipudi K, et al. Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res. 2009;8:5093-102.
14. Baldini C, et al. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther. 2011;13:R194.
15. Ferraccioli G, et al. Proteomic approaches to Sjögren's syndrome: A clue to interpret the pathophysiology and organ involvement of the disease. Autoimmun Rev. 2010;9:622-6.
16. Imanguli M, et al. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp Hematol. 2007;35:184-92.
17. Baum BJ, et al. Scientific frontiers: Emerging technologies for salivary diagnostics. Adv Dent Res. 2011;23(4):360-8.
18. Loo JA, et al. Comparative human salivary and plasma proteomes. J Dent Res. 2010;89(10):1016-23.
19. Schubert MM, et al. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Cancer. 1992;69:2469-77.
20. Ambatipudi KS, et al. Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res. 2009;8(11):5093-102.
21. Wang G, et al. Label-free protein Quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteome. J Proteome Res. 2006;5:1214-23.
22. Mitchell SA, et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant. 2010;45(4):762-9.
23. Liao H, et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 2004;50(12):3792-803.
24. Wijkstrom-Frei C, et al. Lactoperoxidase and human airway host defense. Am J Respir Cell Mol Biol. 2003;29(2):206-12.
25. Yamaguchi Y, et al. Virucidal effects of glucose oxidase and peroxidase or their protein conjugates on human immunodeficiency virus type 1. Antimicrob Agents Chemother. 1993;37(1):26-31.
26. He J, Furmanski P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature. 1995;373(6516):721-4.
27. Travis SM, Singh PK, Welsh MJ. Antimicrobial peptides and proteins in the innate defense of the airway surface. Curr Opin Immunol. 2001;13(1):89-95.
28. Curran CS, Demick KP, Mansfield JM. Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways. Cell Immunol. 2006;242(1):23-30.
29. Grey A, et al. The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol. 2004;18(9):2268-78.
30. Inoue M, et al. Lactoferrin for gut GVHD. Bone Marrow Transplant. 2001;28(11):1091-2.
31. Al-Hashimi I, Dickinson D, Levine M. Purification, molecular cloning, and sequencing of salivary cystatin SA-1. J Biol Chem. 1997;263:9381-987.
32. Freije JP, et al. Human cystatin D. cDNA cloning, characterization of the Escherichia coli expressed inhibitor, and identification of the native protein in saliva. J Biol Chem. 1993;268(21):15737-44.
33. Collins AR, Grubb A. Cystatin D, a natural salivary cysteine protease inhibitor, inhibits coronavirus replication at its physiologic concentration. Oral Microbiol Immunol. 1998;13(1):59-61.
34. Dawes C, Macpherson LM. Effects of nine different chewing-gums and lozenges on salivary flow rate and pH. Caries Res. 1992;26(3):176-82.
35. Nagler RM, Nagler A. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease-a prolonged study. Cancer Invest. 2003;21(1):34-40.
36. Washburn M, Wolters D, Yates JI. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol. 2001;19:242-7.
37. Nilsson T, et al. Mass spectrometry in high-throughput proteomics: ready for the big time. Nat Methods. 2010;7(9):681-5.
38. Baum BJ, et al. Therapy-induced dysfunction of salivary glands: implications for oral health. Spec Care Dentist. 1985;5(6):274-7.
39. Izutsu KT, et al. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation. 1983;35(5):441-6.
40. Addona T, et al. Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol. 2009;27:633-41.
41. Keshishian H, et al. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics. 2007;6:2212-29.
42. Jaffe J, et al. Accurate Inclusion Mass Screening. Mol Cell Proteomics. 2008;7:1952-62.